In a statement on Monday, Ambu reports that the employee representative on its board has sold shares for just under DKK 1m (USD 150,000).
Jakob Bønnelykke Kristensen sold 5,000 shares in the company at a price of DKK 198.5 (USD 30) each on Friday, Nov. 26.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.